DexCom, Inc. Stock Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
15:55:01 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 71.80 EUR | -1.10% |
|
-7.47% | +25.92% |
| 09-09 | DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM | |
| 08-24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| Market Cap | 31.9B 27.42B 25.84B 23.55B 44.03B 3,034B 44.2B 306B 118B 1,547B 120B 117B 4,898B | P/E 2026 * |
33.6x | P/E 2027 * | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 31.14B 26.77B 25.22B 22.98B 42.98B 2,962B 43.15B 298B 115B 1,510B 117B 114B 4,781B | EV / Sales 2026 * |
5.95x | EV / Sales 2027 * | 5.32x |
| Free-Float |
91.27% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DXCM | Delayed | |
CBOE
| DXCM | Real-time | |
Mexican S.E.
| DXCM * | End-of-day quote | |
Tradegate
| DC4 | Real-time | |
Boerse Muenchen
| DC4 | Real-time | |
London S.E.
| 0A4M | Delayed | |
Borsa Italiana
| 1DXCM | End-of-day quote | |
Deutsche Boerse AG
| DC4 | Delayed | |
Börse Stuttgart
| DC4 | Delayed | |
Xetra
| DC4 | Delayed | |
Wiener Boerse
| DXCM | End-of-day quote | |
Swiss Exchange
| DXCM | Delayed | |
Swiss Exchange
| DXCM | Delayed |
Last Transcript : DexCom, Inc.
| 1 day | -1.10% | ||
| 1 week | -7.47% | ||
| Current month | -8.42% | ||
| 1 month | -1.91% | ||
| 3 months | +7.81% | ||
| 6 months | +22.38% | ||
| Current year | +25.92% |
| 1 week | 71.8 | 77.8 | |
| 1 month | 71.8 | 79.2 | |
| Current year | 48.5 | 79.2 | |
| 1 year | 46.88 | 79.2 | |
| 3 years | 46.88 | 131.88 | |
| 5 years | 46.88 | 144.55 | |
| 10 years | 9.12 | 144.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 47 | 2025-12-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 46 | 2021-03-18 |
Stacey Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 68 | 2018-07-29 |
Nick Augustinos
BRD | Director/Board Member | 67 | 2009-11-19 |
Jacob Leach
BRD | Director/Board Member | 47 | 2025-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.10% | -7.47% | - | - | 31.9B | ||
| -0.27% | -3.40% | -20.40% | +4.47% | 183B | ||
| -0.54% | -0.16% | -1.18% | +14.92% | 118B | ||
| -0.42% | -2.31% | +8.55% | +81.95% | 61.96B | ||
| -0.49% | -6.75% | +11.83% | +44.52% | 50.6B | ||
| +0.98% | -3.91% | -6.15% | -32.60% | 48.78B | ||
| -0.77% | -6.94% | +7.54% | -19.62% | 31.9B | ||
| -1.84% | -3.02% | - | - | 30.44B | ||
| -0.24% | -0.50% | +33.10% | -14.30% | 23.77B | ||
| -2.51% | -10.87% | -14.66% | +6.30% | 22.26B | ||
| Average | -0.72% | -2.73% | +2.33% | +10.71% | 63.39B | |
| Weighted average by Cap. | -0.49% | -1.89% | -4.32% | +13.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.23B 4.5B 4.24B 3.86B 7.22B 498B 7.25B 50.09B 19.37B 254B 19.63B 19.21B 803B | 5.8B 4.99B 4.7B 4.28B 8.01B 552B 8.04B 55.55B 21.48B 281B 21.77B 21.3B 890B |
| Net income | 974M 838M 789M 719M 1.34B 92.69B 1.35B 9.33B 3.61B 47.24B 3.66B 3.58B 150B | 1.15B 988M 931M 848M 1.59B 109B 1.59B 11B 4.26B 55.71B 4.31B 4.22B 176B |
| Net Debt | -761M -654M -617M -562M -1.05B -72.41B -1.05B -7.29B -2.82B -36.9B -2.86B -2.8B -117B | -1.06B -912M -860M -784M -1.47B -101B -1.47B -10.17B -3.93B -51.47B -3.98B -3.9B -163B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | €72.40 | -0.28% | 22 |
| 26-09-08 | €72.60 | -2.42% | 0 |
| 26-09-07 | €74.40 | -1.59% | 0 |
| 26-09-04 | €75.60 | -1.82% | 0 |
| 26-09-03 | €77.00 | -0.52% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
Select your edition
All financial news and data tailored to specific country editions



















